Prevalence and Clinical Significance of Anti-annexin A2 Antibodies in COVID-19 Infection
Prevalence and Clinical Significance of Anti-annexin A2 Antibodies in COVID-19 Infection
Recruiting · NCT05242159 · Registry updated 2026-06-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prevalence and Clinical Significance of Anti-annexin A2 Antibodies in COVID-19 Infection | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Not stated | 2026-06-15 | NCT05242159 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centre Hospitalier Universitaire, Amiens | 198 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHU Amiens | Amiens | France | 47 |